MedPath

egacy Effects of PCSK9 Inhibitors on Lipid-Rich Vulnerable Coronary Plaque

Not Applicable
Conditions
acute coronary syndrome
Registration Number
JPRN-UMIN000041925
Lead Sponsor
Gifu Heart Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
7
Inclusion Criteria

Not provided

Exclusion Criteria

A pregnancy or inability to provide written informed consent, Participants had already had anti-PCSK9 antibody on admission

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath